Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta adrenergic agonists

L P Sterling

    AACN Clinical Issues
    |May 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Beta adrenergic agonists are effective for managing bronchospasm. While newer agents offer improved tolerance, potential side effects and debated mortality risks require consideration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Drug therapy in an aging population.

    The Journal of practical nursing·1993
    Same author

    The clinical management of gout.

    American pharmacy·1991
    Same author

    Rheumatoid arthritis: current concepts and management, Part 2.

    American pharmacy·1990
    Same author

    Rheumatoid arthritis: current concepts and management, Part 1.

    American pharmacy·1990
    Same author

    Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.

    Antimicrobial agents and chemotherapy·1989
    Same journal

    Metabolic syndrome in the acute care setting.

    AACN clinical issues·2006
    Same journal

    Endocrine problems in critically ill children: an overview.

    AACN clinical issues·2006
    Same journal

    Management of hyperglycemic emergencies.

    AACN clinical issues·2006
    Same journal

    Hyperglycemia in the critically ill patient.

    AACN clinical issues·2006
    Same journal

    The hypothalamic-pituitary-adrenal axis in critical illness.

    AACN clinical issues·2006
    Same journal

    HIV peripheral neuropathy: pathophysiology and clinical implications.

    AACN clinical issues·2006
    See all related articles

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Clinical Therapeutics

    Background:

    • Beta adrenergic agonists are primary treatments for bronchospasm due to rapid action.
    • Inhaled administration offers benefits like faster effects and reduced side effects.
    • Newer agents possess enhanced beta-2 selectivity, improving patient tolerance.

    Purpose of the Study:

    • To review the efficacy and safety of beta adrenergic agonists in bronchospasm management.
    • To discuss the advantages of inhaled administration and newer selective agents.
    • To address controversies regarding adverse effects and mortality associated with these agents.

    Main Methods:

    • Literature review of studies on beta adrenergic agonists.
    • Analysis of efficacy, safety profiles, and administration routes.

    Related Experiment Videos

  • Examination of reported adverse events and mortality data.

    • Main Results:

    • Beta adrenergic agonists provide rapid and effective bronchospasm relief.
    • Inhaled delivery enhances therapeutic benefits and minimizes systemic exposure.
    • Common side effects include tremor, tachycardia, and hypokalemia; tremor is dose-limiting.
    • Controversies exist regarding increased mortality with higher usage, but data remain inconclusive.

    Conclusions:

    • Beta adrenergic agonists remain crucial for acute bronchospasm.
    • Current evidence does not support limiting their use due to mortality concerns.
    • Further research is needed on tolerance with prolonged administration.